Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Celyad
Celyad is a biotechnology company developing immunotherapies for treating cancer.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Company
Organization
AngelList URL
angel.co/cardio3-biosciences
Board of Directors
Chris Buyse
0
Hilde Windels
0
Dominic Piscitelli
0
CIK Number
1,637,890
0
Legal Name
Celyad Oncology SA
Company Operating Status
Active
Contact Page URL
celyad.com/contact-us/
Country
Belgium
Crunchbase URL
crunchbase.com/organiz...sciences
Date Incorporated
2007
Email Address
www.celyad.com
info@celyad.com
0
Fax Number
+32(0) 10 39 41 41
0
Founded Date
2007
Full Address
60 Broad Street Suite 3502 New York, NY 10004 USA
0
Axis Business Park Rue Edouard Belin 2 1435 Mont-Saint-Guibert Belgium
0
Industry
CAR T-Cell therapy
Stem cell
Regenerative medicine
Healthcare
Biopharmaceutical
Medicine
Therapeutics
Technology
Biomedical engineering
Tissue engineering
•••
Investors
S.R.I.W.
LinkedIn URL
@company/celyad
Location
New York
Mont-Saint-Guibert
0
Belgium
United States
New York City
0
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Phone Number
+18579906900
0
+3210394100
0
Pitchbook URL
pitchbook.com/profiles.../56851-48
Place of Incorporation
Belgium
0
Previous Name
CELYAD S.A.
0
CARDIO3 BIOSCIENCES S.A.
0
Public/Private
Private
0
SIC Code
2,834
0
Exchange
Nasdaq
Ticker Symbol
CYAD
Twitter URL
@celyadsa
Official Website
c3bs.com
celyad.com
Wellfound ID
cardio3-biosciences
YouTube Channel
youtube.com/channel/U...L94Vdj5aVA
Find more companies like Celyad
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE